Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


BIOGEN, INC.

Cambridge, MA US

BIOGEN, INC. Patent applications
Patent application numberTitlePublished
20110177093USE OF BCMA AS AN IMMUNOREGULATORY AGENT - The disclosure relates to B-cell maturation antigen (BCMA), a receptor for APRIL and BAFF, and its use as an immunoregulatory agent in treatment of immunological disorders such as multiple sclerosis. The disclosure provides methods and compositions for treating neurodegenerative immunological disorders in mammals by administering soluble BCMA, an antibody against BCMA, or an antibody against a BCMA ligand, e.g., APRIL or BAFF.07-21-2011
20100260761ANTIBODIES SPECIFICALLY REACTIVE WITH A TUMOR NECROSIS FACTOR RELATED LIGAND - The present invention relates to antibodies that bind Tumor Necrosis Factor Related Ligand (TRELL), a novel member of the tumor necrosis factor family (TNF), modified TRELL, and pharmaceutical compositions comprising them.10-14-2010

Patent applications by BIOGEN, INC.